金融时报
微生物学
膜
化学
生物
细菌
细菌蛋白
生物化学
遗传学
作者
Xianyuan Wei,Jun Guo,Xinyu Geng,Xue Bai,Shaohui Huang,Zhen Yuan
标识
DOI:10.1002/adhm.202304600
摘要
Abstract The emergence of multidrug‐resistant (MDR) bacteria poses a significant challenge to global health. Due to a shortage of antibiotics, alternative therapeutic strategies are urgently needed. Unfortunately, colistin, the last‐resort antibiotic, has unavoidable nephrotoxicity and hepatotoxicity, and its single killing mechanism is prone to drug resistance. To address this challenge, we propose a promising combinatorial approach that includes colistin, a membrane‐disrupting antimicrobial agent, and chelerythrine (CHE), a FtsZ protein inhibitor. This approach significantly reduces antibiotic dose and development of resistance, leading to almost complete inactivation of MDR pathogens in vitro. To address solubility issues and ensure transport, we used the antimicrobial hydrogel system LNP‐CHE‐CST@hydrogel, which induced reactive oxygen species (ROS) and apoptosis‐like cell death by targeting the FtsZ protein. In an in vivo mouse skin infection model, the combination therapy effectively eliminated MDR bacteria within 24 hours, as monitored by fluorescence tracking. Our findings demonstrate a promising approach for developing multifunctional hydrogels to combat MDR bacterial infections. This article is protected by copyright. All rights reserved
科研通智能强力驱动
Strongly Powered by AbleSci AI